As of November 12, 2026, the contents on file for 7Tabz are 7-hydroxymitragynine (7Tabz 7-OH tablets), per an FDA warning letter, 7-hydroxymitragynine (7Tabz 7-Hydroxy+Pseudo tablets), per an FDA warning letter and 7-Hydroxymitragynine (Product Facts panel, 7Tabz 15 mg 4-pack). Judged product by product, by the law on file for each product’s ingredients: 7Tabz 7-OH tablets (7-OH) is illegal in 17, restricted in 19, gray area in 6, legal in 9; 7Tabz 7-Hydroxy+Pseudo tablets (7-OH) is illegal in 17, restricted in 19, gray area in 6, legal in 9 of 51 jurisdictions. Official actions on file: 3 (FDA, June 25, 2025, FDA, July 15, 2025 and Court record, January 23, 2026). Federal: FDA issued a warning letter to 7Tabz Retail, LLC on June 25, 2025 over its 7-OH tablets.
Derived only from the ingredients on file (label or official source, as marked) and the law on file for each. Checked November 7, 2026.
FDA, June 25, 2025: FDA sent a warning letter to 7Tabz Retail, LLC (Tampa, Florida) about 7Tabz 7-OH tablets (15 mg and 30 mg per tablet) and 7Tabz 7-Hydroxy+Pseudo tablets (20 mg per tablet), stating they are unapproved new drugs and, where sold as dietary supplements, adulterated because 7-OH is a new dietary ingredient without adequate safety information. Read the FDA document
FDA, July 15, 2025: FDA announced warning letters to seven firms marketing 7-hydroxymitragynine products, including 7Tabz Retail, LLC. Read the FDA document
Court record, January 23, 2026: A putative class action filed in the Southern District of California (No. 3:26-cv-00440) against 7Tabz Retail, LLC and 7Tabz Distribution, LLC alleges that 7Tabz 7-OH tablets were marketed as natural and safe without warnings about addiction and other health risks; these are allegations. Read the court record
What is in it: label and official sources
The brand’s sites could not be read. The 7Tabz 7-OH 15 mg 4-pack card was read by hand from a retailer product photo: Product Facts panel, 7-hydroxymitragynine 7.5 mg per 1/2 tablet serving, distributed by 7Tabz Distribution, Tampa, FL. FDA's warning letter names the 15 mg, 30 mg and 7-Hydroxy+Pseudo 20 mg tablets.
7-hydroxymitragynine (7Tabz 7-OH tablets) · 15 mg per tablet (and a 30 mg tablet), as marketed and quoted in the FDA warning letter · Is 7-OH legal? Source: an FDA warning letter
7-hydroxymitragynine (7Tabz 7-Hydroxy+Pseudo tablets) · 20 mg per tablet per the product name; FDA says the products are marketed to contain 7-OH and does not say what Pseudo refers to · Is 7-OH legal? Source: an FDA warning letter
7-Hydroxymitragynine (Product Facts panel, 7Tabz 15 mg 4-pack) · 7.5 mg per serving of 1/2 tablet (15 mg per tablet), 8 servings; ingredient listed as Mitragyna speciosa (kratom) leaf extract; other ingredients microcrystalline cellulose, dicalcium phosphate, silicon dioxide, magnesium stearate, colorant (retailer product photo) · Is 7-OH legal? Label source
Only ingredients disclosed on the label or identified by an official source (FDA, another government agency or lab, an accredited lab or a court record) are listed, each with its source. Compound Laws does not guess at undisclosed contents.
Federal
FDA issued a warning letter to 7Tabz Retail, LLC on June 25, 2025 over its 7-OH tablets. Source
7Tabz ingredients by state
7Tabz 7-OH tablets
7-OH: illegal in 17, restricted in 19, gray area in 6, legal in 9 of 51.
Compound Analytics. "Is 7Tabz Legal? Ingredients and State Laws (2026)." Compound Laws, https://compoundlaws.com/brands/7tabz/. Accessed November 13, 2026.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.